Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.
Source: cnbc.com
Page 6 - Jay Bradner News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jay Bradner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jay Bradner Today - Breaking & Trending Today
Baystreet.ca - Amgen Scraps Weight-Loss Pill
Amgen (NASDAQ:AMGN) on Thursday said it will stop developing its experimental weight loss pill and instead move forward with its injectable drug and other products in development for obesity. Amgen is among several drugmakers racing to join the ...
Source: baystreet.ca
Amgen scraps experimental weight loss pill, moves forward with injection
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.
Source: cnbc.com
Amgen scraps experimental weight loss pill, moves forward with injection
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.
Source: nbcsandiego.com
Amgen Soars After CEO Gives Update on Experimental Obesity Drug
(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineApple Rallies Most in 18 Months on Upbeat Forecast, BuybackEverything Apple Plans to Show at May 7 ‘Let Loose’ iPad EventTrump Auditions VP Picks Before Wealthy Donors in Palm BeachTurkey Confirms All Trade Halt With Israel
Source: yahoo.com